CDIO
CDIO
NASDAQ · Biotechnology

Cardio Diagnostics Holdings

$1.97
+0.09 (+4.52%)
As of Mar 29, 11:05 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,580.9% upside
Low Target $21.42
Average Target $33.03
High Target $37.66
Current Price $1.97
Current
$1.97
Target
$33.03
$21.42 $33.03 avg $37.66
Scenario Analysis
Bear Case
$21.42
990.1%
Low target
Base Case
$33.03
+1,580.9%
Avg target
Bull Case
$37.66
+1,816.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$17.39
-88.7% from high
52-Week Low
$0.97
+102.6% from low
Target vs 52W High
$33.03
+89.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%